News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Leaman John Harold
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/04/2023 |
4
| Leaman John Harold (Chief Fin. & Business Officer) has filed a Form 4 on IMPEL PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 3,627 shares
@ $3.75, valued at
$13.6k
Exercised 10,571 options to buy
@ $0 |
|
| 01/28/2022 |
4
| Leaman John Harold (Chief Fin. & Business Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 100,000 options to buy
@ $9.85, valued at
$985k
|
|
| 10/21/2021 |
4
| Leaman John Harold (Chief Fin. & Business Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 10,571 options to buy
@ $0 |
|
| 07/26/2021 |
4
| Leaman John Harold (CFO) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $12.16, valued at
$608k
|
|
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/19/2018 |
4
| Leaman John Harold (CFO, Treas. & Hd Corp Strategy) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 50,000 options to buy
@ $12.75, valued at
$637.5k
|
|
| 11/20/2017 |
4
| Leaman John Harold (CFO, Treas. & Hd Corp Strategy) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 220,000 options to buy
@ $10.23, valued at
$2.3M
|
|
| 10/26/2017 |
3
| Leaman John Harold (CFO, Treas. & Hd Corp Strategy) has filed a Form 3 on SELECTA BIOSCIENCES INC |
|
|